Scroll to top
Follow Us
–
Skip to content
̍̍ CSE:
BRAX
̍̍ OTC:
BRAXF
̍̍ FWB:
4960
Home
Company
About Us
Leadership
Board of Directors
Clinics
Our Clinics
Braxia Institute
Media
Investors
Investor Relations
Investor Materials
Annual General Meeting 2024
Annual General Meeting 2022
Annual General Meeting 2021
News
News Releases
Events
Company
About Us
Leadership
Board of Directors
Clinics
Our Clinics
Braxia Institute
Media
Investors
Investor Relations
Investor Materials
Annual General Meeting 2022
Annual General Meeting 2021
News
News Releases
Events
©2022 Braxia Scientific Corp.
DISCLAIMER
— The information on this site should not be used to make decisions about medical treatments. Please conduct your own research and due diligence before making any major health changes. Braxia Scientific, its members, directors, employees, and representatives are not responsible for damages of any nature arising out of or relating to the use of this website or any hyperlinked websites. The material that appears on this website is for informational purposes only. Braxia Scientific has made every effort to provide useful and accurate information. However, errors may appear from time to time. Braxia Scientific and its information providers make no warranty as to the reliability, timeliness, completeness, accuracy or usefulness of the information on the website. Any opinion, view, or idea contained in an article, story or column published on this website is that of the author and does not reflect or represent the views of Braxia Scientific or any of its members, directors, employees and representatives.
Follow Us
–
Go back
Ketamine Treatment Goes Mainstream
Tag
Home
Tag: Ketamine Treatment Goes Mainstream
Showing 1-1 of 1 results
Categories
Events
Media
News Releases
Tags
2022
41st Annual
Acquisition
Adrienne Arsht Center for the Performing Arts of Miami-Dade County
Advisory Board
AIMDAY
AMERICAN JOURNAL OF PSYCHIATRY
Annual General Meeting
Annual Global Investment Conference
ANNUAL GROWTH CONFERENCE
Annual Mental Health Conference
At-Home Telemedicine Platform
AWARDED
BIPOLAR
brain
BRAXF
braxia academy
Braxia Health
BRAXIA INSTITUTE
BRAXIA SCIENTIFIC
CANACCORD GENUITY
Canada'
Canadians
CBC
CEO
Champion
Children
chronic stress
Clinic
Clinical
Clinical Ketamine Treatment
CLINICAL THERAPY
CLINICAL TRIAL
cohort
CONFERENCE
CORPORATE UPDATE
COVID-19
CTV
curfew
DEPRESSION
Depressive
DEVELOPMENT
DISCOVERY
Documentary
DR. ROGER MCINTYRE
Drug Development
ENROLLMENT
ESKETAMINE
EXPERIMENTAL MEDICINE
Financial Report
Financial Result
FINANCIAL RESULTS
Financial Results; Corporate Update
First Quarter
FISCAL
FOURTH QUARTER
FUNDING
Germ Fear
Global Investment Conference
GOVERNMENT OF CANADA
Growth
Growth Conference
GUIDANCE
H.C. Wainwright
H.C. WAINWRIGHT & CO
Harnessing the Power of Psychedelic Drug Therapy
Health Canada
Institutional Investors
Intent to Acquire
INTERNATIONAL
International Conference
Irwin Naturals
Journal of the Royal Society of Medicine
KetaMD
KETAMINE
Ketamine Guidelines
ketamine research
ketamine telemedicine
Ketamine Treatment
Ketamine Treatment Goes Mainstream
ketamine treatments
ketamine treatments for depression
Keynote
Lamar Odom
Landmark
LIFE Offering
LOI
Loneliness
MARKETS
Matt Galloway
Medical Professionals
MEDICINE
mental
Mental Health
Mental Health Platform
Mental Healthcare
Miami
Milestone
Montreal
Mood Disorders
Multi-Dose
Multiple-Dose
NBA
Neuropsychiatry
New York Times
News
OTC
OXFORD UNIVERSITY
Pandemic
pandemic loneliness
Parenting
Patient
PHYSICIANS
Presentation
Private Placement
Psilocybin
Psilocybin and Ketamine in Canada
psilocybin treatment
Psilocybin Treatments for Depression
Psilocybin Trial
PSILOCYBIN-ASSISTED
Psilocybin-Assisted Therapy
Psilocybin-Assisted Therapy Training Program
PSYCH INVESTOR SUMMIT
Psychedelic
Psychedelic Invest
Psychedelic Research
PSYCHEDELICS
PSYCHIATRIC
PSYCHIATRIC TREATMENT
PSYCHIATRY
PSYCHOLOGISTS
PSYCHOTHERAPISTS
Q2
QUEBEC
Reduction
reporting
REPORTS
Research
RESEARCHERS
Results
Revenue
Second Quarter
Series
Shareholders
Solo Treatment
Special Access Program
STOCK SYMBOL
Study
Suicidality
Suicide
Symptoms
THERAPY CLINIC
Therapy for Depression
Toronto
training program
Treat Brain-Based Illnesses
TREATMENT
Treatment Resistant
Treatment Resistant Depression
treatments for patients
Vancouver
Virtual Conference
Virtual Ketamine Treatments
W5
Webcast
Wonderland
Wonderland Miami
Work from home
Zappy Zapolin
Filter
November 8, 2021
Braxia Scientific CEO Dr. Roger McIntyre to Deliver Keynote Address at Wonderland: Miami
See the full press release
Read More